Paper29436639
Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling.
Tan JY and 5 others. Mol Med Rep, 2018. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling. Papers, record 29436639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29436639
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Glycyrrhizic Acid | Major topic |
| HMGB1 Protein | Major topic |
| Monocytes | Major topic |
| Signal Transduction | Major topic |
| Cell Line | |
| Cell Movement | |
| Chemokine CCL2 | |
| Extracellular Signal-Regulated MAP Kinases | |
| Humans | |
| Mitogen-Activated Protein Kinases | |
| NF-kappa B |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40070780 | Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis. | Oncol Lett | 2025 | https://conductscience.org/library/papers/40070780 | PubMed |
| 38802470 | Trimebutine prevents corneal inflammation in a rat alkali burn model. | Sci Rep | 2024 | https://conductscience.org/library/papers/38802470 | PubMed |
| 38771510 | Glycyrrhizic Acid Alleviates Semen Strychni-Induced Neurotoxicity Through the Inhibition of HMGB1 Phosphorylation and Inflammatory Responses. | J Neuroimmune Pharmacol | 2024 | https://conductscience.org/library/papers/38771510 | PubMed |
| 37601451 | Effect of HMGB1 and HBD-3 levels in the diagnosis of sepsis- A comparative descriptive study. | Biochem Biophys Rep | 2023 | https://conductscience.org/library/papers/37601451 | PubMed |
| 37446230 | Inflammation of Dry Eye Syndrome: A Cellular Study of the Epithelial and Macrophagic Involvement of NFAT5 and RAGE. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446230 | PubMed |
| 36906519 | Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis. | BMC Musculoskelet Disord | 2023 | https://conductscience.org/library/papers/36906519 | PubMed |
| 36313350 | Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36313350 | PubMed |
| 35646138 | Medication Rules in Herbal Medicine for Mild Cognitive Impairment: A Network Pharmacology and Data Mining Study. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35646138 | PubMed |
| 35586052 | Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35586052 | PubMed |
| 34904016 | Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34904016 | PubMed |
| 33192202 | Induced Pluripotent Stem Cells Attenuate Acute Lung Injury Induced by Ischemia Reperfusion via Suppressing the High Mobility Group Box-1. | Dose Response | 2020 | https://conductscience.org/library/papers/33192202 | PubMed |
| 32660524 | High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32660524 | PubMed |
| 32431618 | Quercetin Attenuates d-GaLN-Induced L02 Cell Damage by Suppressing Oxidative Stress and Mitochondrial Apoptosis via Inhibition of HMGB1. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32431618 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL2 | 6347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MCL1 | 4170 | PubTator's text mining | https://conductscience.org/library/genes/4170 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29436639
GET https://conductscience.org/api/papers/v1/29436639/authors